Clinical trial
A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life
NCT00222105 · University of Kansas Medical Center, Other · Completed
Key facts
| NCT number | NCT00222105 |
|---|---|
| Title | A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life |
| Official title | Doxil® (Pegylated Liposomal Doxorubicin), Dexamethasone Plus Thalidomide (Ddt) in Previously Untreated Multiple Myeloma: A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life |
| Lead sponsor | University of Kansas Medical Center, Other |
| Collaborators | Ortho Biotech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Doxil, Thalidomide, Dexamethasone |
| Enrollment | 25 |
| Start date | Nov 1, 2002 |
| Primary completion | Apr 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Sep 22, 2005 |
| Last update posted | Jul 2, 2017 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: